266 reports of this reaction
0.4% of all NYSTATIN reports
#100 most reported adverse reaction
PRODUCTIVE COUGH is the #100 most commonly reported adverse reaction for NYSTATIN, manufactured by Padagis US LLC. There are 266 FDA adverse event reports linking NYSTATIN to PRODUCTIVE COUGH. This represents approximately 0.4% of all 59,130 adverse event reports for this drug.
NYSTATIN has an overall safety score of 82 out of 100. Patients taking NYSTATIN who experience productive cough should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PRODUCTIVE COUGH is a less commonly reported adverse event for NYSTATIN, but still significant enough to appear in the safety profile.
In addition to productive cough, the following adverse reactions have been reported for NYSTATIN:
The following drugs have also been linked to productive cough in FDA adverse event reports:
PRODUCTIVE COUGH has been reported as an adverse event in 266 FDA reports for NYSTATIN. This does not prove causation, but indicates an association observed in post-market surveillance data.
PRODUCTIVE COUGH accounts for approximately 0.4% of all adverse event reports for NYSTATIN, making it a notable side effect.
If you experience productive cough while taking NYSTATIN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.